K-Stat-ET Tablet
Marketer
Mercury Laboratories Ltd
Salt Composition
Tranexamic Acid (500mg) + Ethamsylate (250mg)
Overview K-Stat-ET Tablet
Combistat-H tablets are a combined medication indicated for managing excessive menstrual bleeding. Their mechanism involves inhibiting clot breakdown, thus controlling heavy bleeding. This effect is enhanced by promoting platelet aggregation and clot formation. Combistat-H can be administered at any time, with or without food, but consistent daily timing is recommended. Continue treatment as directed by your physician. Follow the prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Abrupt cessation should be avoided without consulting your doctor. Common adverse reactions include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is possible; increased fluid intake is advisable to mitigate dehydration. If menstrual flow doesn't improve after three consecutive cycles, seek medical attention. Prior to commencing treatment, inform your doctor of any kidney issues or vaginal bleeding disorders. Pregnant or lactating individuals should consult their doctor before use. Always disclose all other medications currently being taken. Regular eye examinations may be requested during treatment.
Uses of K-Stat-ET Tablet
Profuse uterine bleeding
Major Benefits of K-Stat-ET Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for K-Stat-ET Tablets. Ingest the tablets whole; do not crush, chew, or divide them. While K-Stat-ET Tablets can be taken with or without food, consistent timing is recommended.
Common Side effects of K-Stat-ET Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use K-Stat-ET Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. K-Stat-ET Tablets can be administered with or without food, although consistent timing is recommended.
How K-Stat-ET Tablet works:
K-Stat-ET tablets contain Tranexamic Acid and Ethamsylate, two medications that work synergistically to manage bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots by inhibiting their degradation. Ethamsylate, a hemostatic drug, enhances platelet aggregation, promoting clot formation and stemming bleeding, particularly from capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of K-Stat-ET tablets and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on K-Stat-ET Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The safety of K-Stat-ET Tablet while breastfeeding is unknown. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by K-Stat-ET Tablet use.
KidneyCAUTION
Patients with impaired kidney function should use K-Stat-ET Tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of K-Stat-ET Tablets in individuals with hepatic impairment appears to present a low risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take K-Stat-ET Tablet :
Should you forget a K-Stat-ET Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About K-Stat-ET Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |



